» Articles » PMID: 31788908

Modeling Pediatric Medulloblastoma

Overview
Journal Brain Pathol
Date 2019 Dec 3
PMID 31788908
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Mouse models of medulloblastoma have proven to be instrumental in understanding disease mechanisms, particularly the role of epigenetic and molecular drivers, and establishing appropriate preclinical pipelines. To date, our research community has developed murine models for all four groups of medulloblastoma, each of which will be critical for the identification and development of new therapeutic approaches. Approaches to modeling medulloblastoma range from genetic engineering with CRISPR/Cas9 or in utero electroporation, to orthotopic and patient-derived orthotopic xenograft systems. Each approach or model presents unique advantages that have ultimately contributed to an appreciation of medulloblastoma heterogeneity and the clinical obstacles that exist for this patient population.

Citing Articles

OLIG2 mediates a rare targetable stem cell fate transition in sonic hedgehog medulloblastoma.

Desai K, Wanggou S, Luis E, Whetstone H, Yu C, Vanner R Nat Commun. 2025; 16(1):1092.

PMID: 39904987 PMC: 11794873. DOI: 10.1038/s41467-024-54858-y.


Human stem cell models to unravel brain cancer.

Dave B, Tailor J BMC Cancer. 2024; 24(1):1465.

PMID: 39609728 PMC: 11603633. DOI: 10.1186/s12885-024-13187-5.


Development of an orthotopic medulloblastoma zebrafish model for rapid drug testing.

van Bree N, Oppelt A, Lindstrom S, Zhou L, Boutin L, Coyle B Neuro Oncol. 2024; 27(3):779-794.

PMID: 39383211 PMC: 11889719. DOI: 10.1093/neuonc/noae210.


Arrested development: the dysfunctional life history of medulloblastoma.

Tao R, Han K, Wu S, Friske J, Roussel M, Northcott P Genes Dev. 2024; 39(1-2):4-17.

PMID: 39231614 PMC: 11789489. DOI: 10.1101/gad.351936.124.


Pediatric Tumors as Disorders of Development: The Case for In Vitro Modeling Based on Human Stem Cells.

Clairmont C, Gell J, Lau C Cancer Control. 2024; 31:10732748241270564.

PMID: 39118322 PMC: 11311176. DOI: 10.1177/10732748241270564.


References
1.
Beckmann P, Larson J, Larsson A, Ostergaard J, Wagner S, Rahrmann E . Insertional Mutagenesis Reveals Important Genetic Drivers of Central Nervous System Embryonal Tumors. Cancer Res. 2019; 79(5):905-917. PMC: 6397665. DOI: 10.1158/0008-5472.CAN-18-1261. View

2.
Northcott P, Korshunov A, Witt H, Hielscher T, Eberhart C, Mack S . Medulloblastoma comprises four distinct molecular variants. J Clin Oncol. 2010; 29(11):1408-14. PMC: 4874239. DOI: 10.1200/JCO.2009.27.4324. View

3.
Lau J, Schmidt C, Markant S, Taylor M, Wechsler-Reya R, Weiss W . Matching mice to malignancy: molecular subgroups and models of medulloblastoma. Childs Nerv Syst. 2012; 28(4):521-32. PMC: 3515664. DOI: 10.1007/s00381-012-1704-1. View

4.
Huang M, Tailor J, Zhen Q, Gillmor A, Miller M, Weishaupt H . Engineering Genetic Predisposition in Human Neuroepithelial Stem Cells Recapitulates Medulloblastoma Tumorigenesis. Cell Stem Cell. 2019; 25(3):433-446.e7. PMC: 6731167. DOI: 10.1016/j.stem.2019.05.013. View

5.
Raleigh D, Choksi P, Krup A, Mayer W, Santos N, Reiter J . Hedgehog signaling drives medulloblastoma growth via CDK6. J Clin Invest. 2017; 128(1):120-124. PMC: 5749513. DOI: 10.1172/JCI92710. View